Skip to Content

ASH2023 AI in Hematology: Enhancing Diagnostic Precision for Two Rare Blood Cancers

In this MEDtalk, Dr. Andrew Srisuwananukorn, Assistant Professor at The Ohio State University, introduces an innovative AI designed to differentiate between pre-fibrotic primary myelofibrosis and essential thrombocythemia, two rare and often confusable blood cancers. Dr. Srisuwananukorn’s research, which will be detailed at ASH2023, has the potential to aid physicians in providing more accurate diagnoses and improving patient outcomes through advanced AI technology.

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top